Thursday, August 16, 2018
 
 
Company News: Page (1) of 1 - 07/12/18 Email this story to a friend. email article Print this page (Article printing at MyDmn.com).print page facebook
Vascular Graft Market: Increasing Geriatric Population and High Prevalence of Aneurysms to Drive the Market

(July 12, 2018)


"The major players operating in Vascular Graft Market are B. Braun (Germany), C. R. Bard (US), Cardinal Health (US), Cook Medical (US), Endologix (US), LeMaitre Vascular (US), Medtronic (Ireland), Maquet (Germany), Terumo (Japan), and Gore Medical (US)."
The global vascular graft market is expected to reach USD 3.80 Billion by 2022 from USD 2.67 Billion in 2017, at a CAGR of 7.3%. Growth in the vascular grafts market is mainly driven by the constant growth in the geriatric population and the corresponding prevalence of aneurysms, increasing incidence of end-stage renal disease, and the growing preference for minimally invasive surgeries.

According to new market research report "Vascular Graft Market by Indication (EVAR, Abdominal Aneurysm Repair, Thoracic Aneurysm, Peripheral Vascular Repair), Raw Material (Polyester, ePTFE, Polyurethane, Biosynthetic), End Users (Hospital, Ambulatory Surgery Center) - Global Forecast to 2022", Published by MarketsandMarkets define, describe, segment, and forecast the vascular grafts market by raw material, indication, end user, and region.

This market covers vascular grafts that are used to treat different types of aneurysms. These vascular grafts, commonly made from polyesters or ePTFE, are used for hemodialysis vascular access and endovascular aneurysm & thoracic aneurysm repair. Factors driving the growth of the vascular grafts market include rising demand for endovascular aneurysm repair procedures, increasing incidences of end-stage renal disorders, and growing geriatric population.

Based on raw material, the vascular grafts market is segmented into polyester grafts, ePTFE grafts, polyurethane grafts, and biosynthetic grafts. Polyester grafts segment is likely to dominate this market in 2017 and this segment is also estimated to register the highest CAGR during the forecast period. The high growth of these segments is primarily attributed to the high adoption of polyester by market players in the manufacturing of vascular grafts and the various advantages offered by this raw material, such as high patency, high porousness, and long lifespan.

Free Sample Pages: https://www.marketsandmarkets.com/pdfdownload.asp?id=179457001

Based on indication, the vascular grafts market is segmented into endovascular aneurysm repair, hemodialysis access, and peripheral vascular aneurysm. The endovascular aneurysm repair segment is expected to hold the largest market share in 2017 and grow at the highest growth rate during the study period. The high growth in this segment is attributed to the increasing demand for endovascular aneurysms repair procedures and increasing prevalence of risk factors that trigger aneurysms such as hypertension and obesity.

Based on end users, the vascular grafts market is segmented into hospitals and ASCs. The hospitals segment dominated the market in 2017 and is expected to grow at the highest CAGR during the forecast period. Factors such as the rising number of MIS procedures in hospitals and favorable Medicare coverage of vascular grafts in most developed countries are driving the growth of this end-user segment.

The global vascular grafts market is segmented in North America, Europe, Asia Pacific and Rest of World. North America dominated the vascular grafts market in 2017, followed by Europe. North America is expected to maintain its dominant share of the global vascular grafts market during the forecast period. Increasing government initiatives to advance the aneurysm treatment and increasing healthcare expenditure are the key factors driving the growth of this regional segment.

Read More: https://www.marketsandmarkets.com/Market-Reports/vascular-graft-market-179457001.html

About MarketsandMarkets™

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets’s flagship competitive intelligence and market research platform, "Knowledgestore" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

Media Contact

Company Name: MarketsandMarketsContact Person: Mr. Shelly Singh


Email: [email protected]
Phone: 1-888-600-6441
Address:630 Dundee Road Suite 430
City: Northbrook
State: IL
Country: United States
Website: https://www.marketsandmarkets.com/Market-Reports/vascular-graft-market-179457001.html



Source: www.abnewswire.com


Page: 1


Related Keywords:Business,Health & Medicine,News & Current Affairs,Pharmaceuticals & Biotech,U.S,
Related Sites: DMN Newswire ,   HTN - Health Technology Net
Related Newsletter: Tutorial Finder ,   Review Seeker ,   DMN Newswire Newsletter
 
 
 
 
 
 
 
Seniors

Drugs
  • Neurovascular Devices Market High Revenue at USD 24,650 mn by 2023 | Therapeutic Application Hemorrhagic & Ischemic Strokes | Worldwide Segmentation by MRFR
  • Wearable Medical Devices Global Market Opportunities And Strategies To 2022
  • New Report Identifies Unique Challenges for LGBT Community Facing Alzheimer's and Other Dementias
  • The Buck Institute, Insilico Medicine, and Juvenescence Found Napa Therapeutics to Develop Drugs to Impede Age-Related Disease,
  • The Buck Institute, Insilico Medicine, and Juvenescence Found Napa Therapeutics to Develop Drugs to Impede Age-Related Disease

    Cancer
  • Biotest AG: Cytotect(R) CP prevents transmission of Cytomegalovirus (CMV) to the unborn baby in pregnant women who are infected with CMV for the first time
  • Agenus Receives Second Milestone Payment from Merck
  • Colorado Pain Care Broadens Practice to Include Cancer Patient Treatment in Denver, CO and Surrounding Area
  • Citius Pharmaceuticals Successfully Raises $10 Million
  • ViewRay Announces Pricing of Public Offering of Common Stock
  •  
     
     
     
     
     





    Our Privacy Policy --- About The Health Technology - Contact Us - Advertise With Us - Privacy Guidelines